RxDoctor Payments Data

Kimberly Bernard

Obstetrics & Gynecology · Coral Springs, FLNPI 1619498417

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,348 of the $3,290 with a category attached, or 71.4%. 28 manufacturers reported payments, led by Coloplast at 32.5% of the total. Reporting peaked in 2023 at $1,486 and has fallen 61.9% since, to $567 in 2025.

$3,290in general payments, 2019–2025

Across 108 payments — averaging $30.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$1K
  • Bayer$269
  • AbbVie$218
  • Astellas Pharma US Inc$197
  • Myovant Sciences Inc.$183
  • Mayne Pharma Commercial LLC$174
  • plus $1K from 22 others

What the payments were for

  • Travel & lodging$84226%
  • Food & beverage$2,34871%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,290 in reported general payments places this provider in the 80th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida →

Other obstetrics & gynecology in Coral Springs

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →